Can failure be predicted in methotrexate treatment with the modified parameter?
Archives of Gynecology and Obstetrics · 2024
DOI: 10.1007/s00404-024-07433-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Yusuf Başkıran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Istinye University Faculty of Medicine, Istanbul, Turkey. yusufbaskiran1@gmail.com. Hauptthemen laut MEDLINE: Methotrexate, Pregnancy, Ectopic, Chorionic Gonadotropin, beta Subunit, Human, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istinye University Faculty of Medicine, Istanbul, Turkey. yusufbaskiran1@gmail.com.
- Van Yuzuncu Yil University Faculty of Medicine, Van, Turkey.
ORCID-Profile: Yusuf Başkıran
Zitieren
APA
Başkıran, Y., Uçkan, K., & Çeleğen, İ. (2024). Can failure be predicted in methotrexate treatment with the modified parameter?. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07433-1
Vancouver
Başkıran Y, Uçkan K, Çeleğen İ. Can failure be predicted in methotrexate treatment with the modified parameter?. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07433-1
BibTeX
@article{Bakran2024,
author = {Başkıran, Yusuf and Uçkan, Kazım and Çeleğen, İzzet},
title = {Can failure be predicted in methotrexate treatment with the modified parameter?},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
doi = {10.1007/s00404-024-07433-1}
}
EUVIMED